![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Ludwig-Maximilians - University of Munich |
---|---|
Information provided by: | Ludwig-Maximilians - University of Munich |
ClinicalTrials.gov Identifier: | NCT00431483 |
The purpose of this study is to establish the impact of a pharmacist's recommendations regarding choice, dosing and duration of antibiotic therapy on quality and cost of antibiotic treatment on surgical wards.
Condition | Intervention |
---|---|
Bacterial Infections |
Behavioral: pharmaceutical consulting |
Study Type: | Interventional |
Study Design: | Supportive Care, Non-Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards |
Estimated Enrollment: | 600 |
Study Start Date: | February 2007 |
Estimated Study Completion Date: | March 2008 |
Inappropriate or incorrect use of antibacterials exerts selection pressure on pathogens potentiating emergence of resistance, puts patients at risk for unnecessary adverse drug reactions and potentially prolongs the length of stay in hospital thus increasing healthcare costs.
In an effort to improve the quality of antibiotic drug therapy on surgical wards of a large university hospital, specific consulting by a clinical pharmacist was established.
The objective of this study is to assess the impact of pharmaceutical consulting on the quality and costs of antibiotic use in surgical wards.
Comparison:
Within a control period the current pattern of antibiotic use is monitored. During the intervention period, the impact of the interventions made by the clinical pharmacist on antibiotic use is examined. One ward serves as a parallel control group; no intervention is being made on this ward throughout this study.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Alexandra Weber, M Pharm | +49-89-7095-2467 | alexandra.weber@med.uni-muenchen.de |
Germany, Bavaria | |
Luwig Maximilians University - Klinikum Grosshadern | Recruiting |
Munich, Bavaria, Germany, 81377 | |
Contact: Alexandra Weber, MPharm 089-7095 ext 2467 alexandra.weber@med.uni-muenchen.de |
Study Director: | Karl-Walter Jauch, Prof. Dr. | Klinikum Grosshadern |
Study ID Numbers: | AW2007 |
Study First Received: | February 1, 2007 |
Last Updated: | November 1, 2007 |
ClinicalTrials.gov Identifier: | NCT00431483 |
Health Authority: | Germany: Ethics Commission |
antibacterial agents surgery pharmacist economics, pharmaceutical |
Bacterial Infections |
Infection |